Patents by Inventor Michael Daniel Sadick

Michael Daniel Sadick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020137113
    Abstract: An assay for measuring activation (i.e., autophosphorylation) of a tyrosine kinase receptor of interest is disclosed.
    Type: Application
    Filed: August 8, 2001
    Publication date: September 26, 2002
    Applicant: Genentech, Inc.
    Inventors: Paul J. Godowski, Melanie R. Mark, Michael Daniel Sadick, Wai Lee Tan Wong
  • Patent number: 6287784
    Abstract: An assay for measuring activation (i.e., autophosphorylation) of a tyrosine kinase receptor of interest is disclosed. (a) A first solid phase is coated with a substantially homogeneous population of cells so that the cells adhere to the first solid phase. The cells have either an endogenous tyrosine kinase receptor or have been transformed with DNA encoding a receptor or “receptor construct” and the DNA has been expressed so that the receptor or receptor construct is presented in the cell membranes of the cells. (b) A ligand is then added to the solid phase having the adhering cells, such that the tyrosine kinase receptor is exposed to the ligand. (c) Following exposure to the ligand, the adherent cells are solubilized, thereby releasing cell lysate. (d) A second solid phase is coated with a capture agent which binds specifically to the tyrosine kinase receptor, or, in the case of a receptor construct, to the flag polypeptide.
    Type: Grant
    Filed: October 13, 1999
    Date of Patent: September 11, 2001
    Assignee: Genentech, Inc.
    Inventors: Paul J. Godowski, Melanie R. Mark, Michael Daniel Sadick, Wai Lee Tan Wong
  • Patent number: 6025145
    Abstract: An assay for measuring activation (i.e., autophosphorylation) of a tyrosine kinase receptor of interest is disclosed. a) A first solid phase is coated with a substantially homogeneous population of cells so that the cells adhere to the first solid phase. The cells have either an endogenous tyrosine kinase receptor or have been transformed with DNA encoding a receptor or "receptor construct" and the DNA has been expressed so that the receptor or receptor construct is presented in the cell membranes of the cells. b) A ligand is then added to the solid phase having the adhering cells, such that the tyrosine kinase receptor is exposed to the ligand. c) Following exposure to the ligand, the adherent cells are solubilized, thereby releasing cell lysate. d) A second solid phase is coated with a capture agent which binds specifically to the tyrosine kinase receptor, or, in the case of a receptor construct to the flag polypeptide.
    Type: Grant
    Filed: January 20, 1995
    Date of Patent: February 15, 2000
    Assignee: Genentech, Inc.
    Inventors: Paul J. Godowski, Melanie R. Mark, Michael Daniel Sadick, Wai Lee Tan Wong